Product Information
DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.5575 per EA under NDC 00115148801. Its NADAC has been published 515 times since Nov 23, 2016.
FDA first approved this application on Feb 16, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 15 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115148801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA076852FDA Approved
2/16/2016
TE Code
AB1
On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 515 times since Nov 23, 2016, and over the history we have for it it has declined 81.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5575 per EA |
|---|---|
| All-time high | $3.0150 (Dec 14, 2016) |
| All-time low | $0.4362 (May 22, 2024) |
| 52-week high | $0.5617 |
| 52-week low | $0.5015 |
| Median price | $0.6912 |
| Average price | $1.1886 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 515 |
| Tracking since | Nov 23, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 15 MG CAP, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.5575 per EA (NDC 00115148801), effective Sep 30, 2026.
How has the price of DEXTROAMP-AMPHET ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has declined 81.5%. It has been tracked across 515 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 15 MG CAP?
Since Nov 23, 2016, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has ranged from a low of $0.4362 (May 22, 2024) to a high of $3.0150 (Dec 14, 2016), with a median of $0.6912 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 15 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 15 MG CAP, is $0.5105 per EA — about 8% below DEXTROAMP-AMPHET ER 15 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 15 MG CAP?
DEXTROAMP-AMPHET ER 15 MG CAP (NDC 00115148801) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.